About Biodexa Pharmaceuticals plc (BDRX) data
Data as of September 30, 2026.
Biodexa Pharmaceuticals plc (BDRX) has 18.38K shares sold short as of the latest FINRA settlement report on September 30, 2026. Short interest has decreased by 93.24% compared with the prior settlement. At the current average daily volume, covering all open short positions would take about 0.03 days (days to cover).
Frequently asked questions
What is the current short interest in BDRX?
As of the latest FINRA settlement dated September 30, 2026, BDRX had approximately 18,380 shares sold short. Short interest data is reported by FINRA twice per month.
How much does it cost to short BDRX?
The latest borrow fee (cost to borrow) for BDRX is 252.60% per year, based on IBKR data. Fees can change throughout the trading day as shares are borrowed and returned.
What is the days to cover ratio for BDRX?
Days to cover for BDRX is approximately 0.03 days. This estimates how many trading days it would take short sellers to buy back all outstanding short shares at the current average daily volume.
How many BDRX shares failed to deliver?
On September 30, 2026, the latest settlement date in the SEC's fails-to-deliver data, 1,067 shares of BDRX had failed to deliver, worth about $693.55 at the prior day's close (0.05% of shares outstanding). That is the balance still outstanding that day, not new fails. Fails come from long sales and delivery delays as well as short sales.
Is BDRX a short squeeze candidate?
A squeeze needs shorts that are hard to close. BDRX trades about 722,370 shares a day and would take roughly 0.03 days to unwind current short positions, at a current borrow fee of 252.60%. Higher days-to-cover and a rising borrow fee together are the setup to watch; neither alone is enough.